While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SGCCTL-NT-pRSGCCG
$300.00
Non-targeting sgRNA in a Cas9 CRISPR lentiviral vector. Used as a CRISPR negative control.